- Previous Close
0.0030 - Open
0.0030 - Bid 0.0030 x --
- Ask 0.0040 x --
- Day's Range
0.0020 - 0.0030 - 52 Week Range
0.0010 - 0.0050 - Volume
4,950,511 - Avg. Volume
3,816,995 - Market Cap (intraday)
9.508M - Beta (5Y Monthly) 2.12
- PE Ratio (TTM)
-- - EPS (TTM)
-0.0000 - Earnings Date Feb 26, 2025 - Mar 3, 2025
- Forward Dividend & Yield --
- Ex-Dividend Date May 19, 1997
- 1y Target Est
--
Avecho Biotechnology Limited, a biotechnology company, engages in the development and commercialization of human and animal health related products using its proprietary drug delivery system and Tocopherol Phosphate Mixture in Australia. The company operates through Production and Human Health segments. It also produces and sells TPM and Vital ET products for use in drug delivery and cosmetic formulations. In addition, the company's human health portfolio covers delivery of pharmaceutical products through gels, injectables, and patches. Further, it develops feed additive products to enhance feed efficiency and the health of livestock animals. The company has a collaboration with Lambert Initiative at the University of Sydney for treatment of osteoarthritis. The company was incorporated in 1992 and is based in Clayton, Australia.
avecho.com.auRecent News: AVE.AX
View MorePerformance Overview: AVE.AX
Trailing total returns as of 1/16/2025, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: AVE.AX
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: AVE.AX
View MoreValuation Measures
Market Cap
9.51M
Enterprise Value
4.89M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
17.38
Price/Book (mrq)
2.25
Enterprise Value/Revenue
9.81
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
0.00%
Return on Assets (ttm)
-44.33%
Return on Equity (ttm)
-108.69%
Revenue (ttm)
339.3k
Net Income Avi to Common (ttm)
-3.48M
Diluted EPS (ttm)
-0.0000
Balance Sheet and Cash Flow
Total Cash (mrq)
4.84M
Total Debt/Equity (mrq)
3.26%
Levered Free Cash Flow (ttm)
-2.1M